v3.26.1
Redeemable Common Stock and Shareholders' Deficit - Summary of Warrant Activity Associated with Equity Financings (Details) - Warrants - USD ($)
$ / shares in Units, $ in Thousands
 3 Months Ended 12 Months Ended
Mar. 31, 2026
Dec. 31, 2025
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Number of Warrants Outstanding, Beginning balance 1,376,056  
Number of Warrants Outstanding Ending balance 1,376,056 1,376,056
Number of Warrants Outstanding, Exercisable 564,790  
Weighted Average Contractual Term (in years), Outstanding 5 years 3 months 5 years 3 months 18 days
Weighted Average Contractual Term (in years), Exercisable 5 years 6 months 3 days  
Weighted Average Exercise Price Per Share, Outstanding, Beginning balance $ 5.91  
Weighted Average Exercise Price Per Share, Outstanding, Ending balance 5.91 $ 5.91
Weighted Average Exercise Price Per Share, Exercisable $ 5.54  
Equity Financing    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Number of Warrants Outstanding, Beginning balance 9,787,769  
Number of Warrants Outstanding Ending balance 9,787,769 9,787,769
Number of Warrants Outstanding, Exercisable 9,787,769  
Weighted Average Contractual Term (in years), Outstanding 5 years 11 months 26 days 6 years 2 months 26 days
Weighted Average Contractual Term (in years), Exercisable 5 years 11 months 26 days  
Aggregate Intrinsic Value, Outstanding, Beginning balance $ 373  
Weighted Average Exercise Price Per Share, Outstanding, Beginning balance $ 2.8  
Weighted Average Exercise Price Per Share, Outstanding, Ending balance 2.8 $ 2.8
Weighted Average Exercise Price Per Share, Exercisable $ 2.8